Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

May 31, 2015

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

fostair

beclometasone dipropionate 200mcg and formoterol 12 mcg delivered by inhaler, twice a day for 28 days

DRUG

placebo

placebo matched inhaler 2puffs to be taken twice a day for 28 days

Trial Locations (1)

HU16 5JQ

Respiratory Medicine Clinical trials Unit, Cottingham

All Listed Sponsors
collaborator

Chiesi Farmaceutici S.p.A.

INDUSTRY

lead

Hull University Teaching Hospitals NHS Trust

OTHER_GOV

NCT02048644 - Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter